妊娠与儿童健康杂志

抽象的

Platelet Parameters Coagulation Profile in Pregnancy Induced Hypertension Cases and Normotensive Pregnancies

Ashika Ridhi

Newly diagnosed hypertension that develops during pregnancy after 20 weeks of gestation and goes away after birth is referred to as pregnancy-induced hypertension. Intrauterine growth restriction (IUGR) and foetal discomfort brought on by PIH have the potential to cause foetal death. A significant health problem that must be addressed, particularly in developing nations, is PIH, which is recognised as a global leading cause of maternal and perinatal morbidity and mortality. Prevalence of hypertensive disorders of pregnancy was recorded in 7.8% of cases in India, whereas concomitant preeclampsia was found in 5.4% of the study population. The two most dangerous side effects are eclampsia and HELLP syndrome (hemolysis, high liver enzymes, and low platelet count). Pre-eclampsia and hypertensive disorders of pregnancy are both frequently associated with hypercoagulability. Thrombocytopenia is the most well-known haematological aberration among all the haematological abnormalities that take place in PIH, and its severity rises as the disease becomes more severe.